Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06424327 · ClinicalTrials.gov registry record
A Registry for People With Lung Cancer
A clinical trial of Lung Cancer and Lung Cancer Stage I, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- 600
- Enrollment target
- 15
- Study locations
NCT06424327: Recruiting study of Lung Cancer and Lung Cancer Stage I, sponsored by Memorial Sloan Kettering Cancer Center.
NCT06424327 is a study of Lung Cancer and Lung Cancer Stage I that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 600 participants, below the 934-participant average among 409 other Lung Cancer trials with a reported enrollment target (36% lower). The trial reports 15 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06424327, a study of Lung Cancer and Lung Cancer Stage I, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- 600 participants
- Enrollment target
- 15
- Study locations
Study Summary
Participants will complete questionnaires before surgery, between 2 to 4 weeks after surgery, and 6 months after surgery.
Conditions Studied
Interventions
- OTHER Patient-Reported Outcomes Measurement Information System
Study Locations (15)
New York
- Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) - Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities) - Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities) - New York
- Memorial Sloan Kettering Nassau (Limited Protocol Activities) - Uniondale
New Jersey
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) - Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) - Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities) - Montvale
Illinois
- Rush University Medical Center (Data collection only) - Chicago
- Endeavor Health - Evanston
Pennsylvania
- Thomas Jefferson University Hospital (Data Collection Only) - Philadelphia
- ALLEGHENY HEALTH NETWORK (Data Collection Only) - Pittsburgh
Michigan
- University of Michigan (Data Collection Only) - Ann Arbor
Texas
- MD Anderson Cancer Center (Data Collection Only) - Houston
Ontario
- University Health Network (Data Collection Only) - Toronto
Quebec
- Centre Hospitalier de l'Université de Montreal (Data Collection Only) - Montreal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2024-05-15 |
| Est. Completion | 2029-05-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06424327
The ClinicalTrials.gov registry entry for NCT06424327 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 934-participant average among 409 other Lung Cancer trials with a reported enrollment target (36% lower). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which Patient-Reported Outcomes Measurement Information System is the first listed.
NCT06424327 reports 15 study locations spanning 8 distinct geographic areas - top geographies include New York, New Jersey, Illinois.
Frequently Asked Questions
What is clinical trial NCT06424327 about?
NCT06424327 is a clinical study titled "A Registry for People With Lung Cancer". Participants will complete questionnaires before surgery, between 2 to 4 weeks after surgery, and 6 months after surgery.
What is the current status of trial NCT06424327?
This trial is currently recruiting. The enrollment target is 600 participants. The study started on 2024-05-15. Estimated completion is 2029-05-15.
What conditions does trial NCT06424327 study?
This clinical trial studies the following conditions: Lung Cancer, Lung Cancer Stage I.
What interventions are being tested in trial NCT06424327?
The interventions under investigation include: Patient-Reported Outcomes Measurement Information System (OTHER).
Who is sponsoring clinical trial NCT06424327?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06424327 being conducted?
This trial has 15 study locations across Illinois, Michigan, New Jersey, New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Health Opportunities and Promoters of Equitable Screening for Lung Cancer
RECRUITING
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.